Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Mitoquinone/mitoquinol mesylate
DRUG
2 trials
Sponsors
University of California, Los Angeles
, University of Texas Southwestern Medical Center
Conditions
Antiviral Treatment
COVID-19
Respiratory Viral Infection
SARS-CoV Infection
Phase 1
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
Completed
NCT05381454
University of California, Los Angeles
Antiviral Treatment, COVID-19, Respiratory Viral Infection
Start: 2022-04-28
End: 2023-05-09
Updated: 2025-12-16
Phase 2
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
Recruiting
NCT05886816
University of Texas Southwestern Medical Center
COVID-19, SARS-CoV Infection
Start: 2024-03-01
End: 2026-07-31
Target: 112
Updated: 2026-03-16
Related Papers
Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls.
2024-03-11
2 citations